Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - Other
Ratios

Cartesian Therapeutics (RNAC) Long-Term Debt Issuances (2020)

Cartesian Therapeutics (RNAC) has disclosed Long-Term Debt Issuances for 1 consecutive years, with -$102000.0 as the latest value for Q4 2020.

  • Quarterly Long-Term Debt Issuances changed N/A to -$102000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was -$102000.0 through Dec 2021, changed 0.0% year-over-year, with the annual reading at $24.7 million for FY2020, N/A changed from the prior year.
  • Long-Term Debt Issuances for Q4 2020 was -$102000.0 at Cartesian Therapeutics.
  • The five-year high for Long-Term Debt Issuances was -$102000.0 in Q4 2020, with the low at -$102000.0 in Q4 2020.